Globus Medical

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Globus Medical and other ETFs, options, and stocks.

About GMED

Globus Medical, Inc. operates as a medical device company that develops and commercializes healthcare solutions. It engages in developing products that promote healing in patients with musculoskeletal disorders. 

CEO
Keith W. Pfeil
CEOKeith W. Pfeil
Employees
6,000
Employees6,000
Headquarters
Audubon, Pennsylvania
HeadquartersAudubon, Pennsylvania
Founded
2003
Founded2003
Employees
6,000
Employees6,000

GMED Key Statistics

Market cap
10.43B
Market cap10.43B
Price-Earnings ratio
17.98
Price-Earnings ratio17.98
Dividend yield
Dividend yield
Average volume
2.19M
Average volume2.19M
High today
$78.11
High today$78.11
Low today
$75.45
Low today$75.45
Open price
$76.38
Open price$76.38
Volume
1.65M
Volume1.65M
52 Week high
$101.40
52 Week high$101.40
52 Week low
$51.79
52 Week low$51.79

Stock Snapshot

As of today, Globus Medical(GMED) shares are valued at $77.21. The company's market cap stands at 10.43B, with a P/E ratio of 17.98.

During the trading session on 2026-05-15, Globus Medical(GMED) shares reached a daily high of $78.11 and a low of $75.45. At a current price of $77.21, the stock is +2.3% higher than the low and still -1.2% under the high.

Trading volume for Globus Medical(GMED) stock has reached 1.65M, versus its average volume of 2.19M.

Over the past 52 weeks, Globus Medical(GMED) stock has traded between a high of $101.40 and a low of $51.79.

Over the past 52 weeks, Globus Medical(GMED) stock has traded between a high of $101.40 and a low of $51.79.

GMED News

Nasdaq 5d
Globus Medical Q1 Earnings Call Highlights

Globus Medical (NYSE:GMED) reported a strong start to 2026, with first-quarter revenue and earnings rising sharply as the company cited continued momentum in U....

Globus Medical Q1 Earnings Call Highlights
Simply Wall St 5d
Why Globus Medical Is Down 5.7% After Raising 2026 Non-GAAP Earnings Guidance And What's Next

In the first quarter of 2026, Globus Medical, Inc. reported sales of US$759.85 million and net income of US$124.30 million, with both basic and diluted earnings...

Why Globus Medical Is Down 5.7% After Raising 2026 Non-GAAP Earnings Guidance And What's Next
TipRanks 6d
Globus Medical Earnings Call Signals Profitable Momentum

Globus Medical ((GMED)) has held its Q1 earnings call. Read on for the main highlights of the call. Claim 55% Off TipRanks Unlock hedge fund-level data and powe...

Analyst ratings

69%

of 16 ratings
Buy
68.8%
Hold
31.3%
Sell
0%

More GMED News

TipRanks 7d
Globus Medical price target lowered to $103 from $104 at Wells Fargo

Wells Fargo analyst Larry Biegelsen lowered the firm’s price target on Globus Medical (GMED) to $103 from $104 and keeps an Overweight rating on the shares. The...

People also own

Based on the portfolios of people who own GMED. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.